SPC
CYTK icon

Sigma Planning Corp’s Cytokinetics CYTK Stock Holding History

Sigma Planning Corp’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
+2,724
New +$196K 0.01% 1243
2020
Q3 		– Sell
-9,700
Closed -$229K – 1081
2020
Q2 		$229K Buy
+9,700
New +$182K 0.01% 887

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sigma Planning Corp's CYTK Position: Q2 2026 in Review

Sigma Planning Corp opened a new position in Cytokinetics (CYTK) in Q2 2026: 2,724 shares worth $232K. The stake represents 0.01% of the portfolio and ranks #1243 among its holdings. This is a return to the name: Sigma Planning Corp previously reported a position in CYTK as recently as Q2 2020.

Sigma Planning Corp first reported a position in CYTK in Q2 2020 and has held it in 2 quarters since. 483 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Sigma Planning Corp held 2,724 shares of Cytokinetics worth $232K as of Q2 2026.
  • Cytokinetics was a new Sigma Planning Corp position in Q2 2026.
  • Cytokinetics made up 0.01% of Sigma Planning Corp's portfolio in Q2 2026, its #1243 holding.
  • Sigma Planning Corp first reported a position in Cytokinetics in Q2 2020 and has held it in 2 quarters since.
  • 483 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.